(Q46407316)

English

Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone

scientific article published in July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

HIV-associated lipodystrophy

1 reference

based on heuristic

inferred from title

Derek C Macallan

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

author name string

Christine Baldwin

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

Sundihya Mandalia

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

Vjera Pandol-Kaljevic

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

Nadine Higgins

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

Alan Grundy

6

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

Graeme J Moyle

7

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

publication date

1 July 2008

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

HIV Clinical Trials

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

9

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

254-268

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

Interventions for managing antiretroviral therapy-associated lipoatrophy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Progression of lipodystrophy (LD) with continued thymidine analogue usage: long-term follow-up from a randomized clinical trial (the PIILR study).

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2 x 2 factorial, randomized, double-blinded, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Metabolic effects of a growth hormone-releasing factor in patients with HIV.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1310%2FHCT0904-254

21 January 2018

Identifiers

10.1310/HCT0904-254

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18753120

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46407316&oldid=2109884170"